Chemotherapy for Non-small Cell Lung Cancer in Elderly Patients

This publication has 20 references indexed in Scilit:

• A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
  British Journal of Cancer, 2004
• Cisplatin-Based Therapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Implications of Eastern Cooperative Oncology Group 5592, a Randomized Trial
  JNCI Journal of the National Cancer Institute, 2002
• Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
  Annals of Oncology, 2002
• A Multicenter Phase II Trial of Vinorelbine Plus Gemcitabine in Previously Untreated Inoperable (Stage IIIB/IV) Non-small Cell Lung Cancer
  Chest, 2000
• Measuring comorbidity in older cancer patients
  European Journal Of Cancer, 2000
• Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
  New England Journal of Medicine, 1999
• Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly
  The Annals of Thoracic Surgery, 1997
• Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study
  European Journal Of Cancer, 1997
• LUNG CANCER IN THE ELDERLY PATIENT
  Clinics in Chest Medicine, 1993
• Characteristics of Lung Cancer in Elderly Patients
  Journal of Gerontology, 1987